Nonnucleoside reverse transcriptase inhibitors
US7348345B2 · kind B2 · utility
5Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2007 |
| Grant date | Mar 25, 2008 |
| Priority date | — |
| Expiry date | Feb 2, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D285/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to methods of treating an HIV infection with novel heterocyclic compounds of formula I wherein R1—R4, X1 and X2 are as defined in the summary and pharmaceutically acceptable salts, and methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.